An exploratory study examined the effects of social networks on lifestyle behaviors in those at risk of type 2 diabetes and cardiovascular disease.
Veronica Hackethal, MD
Researchers investigated the possibility of an SGLT2 inhibitor having two distinct dual glucose-lowering mechanisms, depending on body weight changes.
Studies have suggested that periodontal therapy may improve glycemic control, although the largest RCT to date has questioned those findings.
Zinc-Α2-glycoprotein is an adipokine thought to be involved in promoting lipolysis, as well as modulating insulin sensitivity.
Is it time to add bariatric/metabolic surgery to diabetes treatment guidelines? What criteria should be used to select candidates for surgery?
Did adding an SGLT2 inhibitor improve glycemic control in patients with type 2 diabetes? A recent meta-analysis explores this question.
The study began with patients receiving saxagliptin plus metformin. Then, patients with glycemic control were randomized to placebo or dapagliflozin.
Skin autofluorescence may be a new, noninvasive technique to assess risk of cardiovascular and renal impairment in type 1 diabetes.
Researchers analyzed renin and markers of inflammation and fibrous components from plaques of patients who had undergone carotid endarterectomy.
What impact, if any, do fasting triglycerides have on cardiovascular and diabetes risk in patients with prediabetes?